Literature DB >> 21826954

[Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer].

A J Scheen1, E Beck, J De Flines, M Rorive.   

Abstract

Obesity and type 2 diabetes are two risk factors of breast cancer, especially after menopause. Underlying mechanisms are multiple and include hyperinsulinism due to insulin resistance (insulin, as insulin-like-growth factor -IGF-, is a growth factor), hyperleptinaemia associated with hypoadiponectinaemia, and high levels of estrogens resulting from aromatization of androgens in adipose tissue. In presence of type 2 diabetes associated with obesity, hyperglycaemia might provide energy substrate promoting tumour growth. These data have therapeutic implications with expected favourable effects of weight loss, resulting in a reduction of fat mass and insulin resistance, and the promising results recently reported with metformin contrasting with the negative effects of exogenous administration of high doses of insulin.

Entities:  

Mesh:

Year:  2011        PMID: 21826954

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  3 in total

1.  The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis.

Authors:  Ali Soroush; Negin Farshchian; Saeid Komasi; Neda Izadi; Nasrin Amirifard; Afshar Shahmohammadi
Journal:  J Cancer Prev       Date:  2016-12-30

2.  Association between Height and Actinic Keratosis: A Nationwide Population-based Study in South Korea.

Authors:  Young Bok Lee; Ji Hyun Lee; Min Ji Kang; Jin-Wou Kim; Dong Soo Yu; Kyung Do Han; Yong Gyu Park
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

3.  Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2.

Authors:  Bin Shi; Xinyu Hu; Huimin He; Wenzheng Fang
Journal:  Oncol Lett       Date:  2021-06-23       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.